Colorectal carcinoma: Nucleosomes, carcinoembryonic antigen and ca 19-9 as apoptotic markers; A comparative study

Journal of Biomedical Science

Volumn 18, Issue 1, 2011, Pages

  Al Shuneigat, Jehad M ^a   Mahgoub, Samir S ^a   Huq, Fazlul ^b  

^a MUTAH UNIVERSITY   (Jordan)

^b University of Sydney   (Australia)

Author keywords

carcinoembryonic antigen (CEA) and CA 19 9; colorectal carcinoma; nucleosomes; tumor marker

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ADULT; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; COLORECTAL CARCINOMA; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; NUCLEOSOME; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TUMOR DIFFERENTIATION; BLOOD; CANCER STAGING; CARCINOMA; COLORECTAL TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; APOPTOSIS; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CARCINOMA; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NUCLEOSOMES; TUMOR MARKERS, BIOLOGICAL;

EID: 79960585486     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-18-50     Document Type: Article

References (32)

1. Multiple serological biomarkers for colorectal cancer detection. CC Chan, CW Fan, YB Kuo, YH Chen, PY Chang, KT Chen, RP Hung, EC Chan, Int J Cancer 2010 126 1683 1690 19795454
2. Detection of apparent methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions. H Zhao-Hut, L Li-Hua, Y Fan, W Jin-Fu, World J Gastroenterol 2007 14 950 954
3. Relationship of diagnostic and therapeutic delay with survival in colorectal cancer: A review. M Ramos, M Esteva, E Cabeza, C Campillo, J Llobera, A Aguilo, European journal of cancer 2007 43 2467 2478 10.1016/j.ejca.2007.08. 023 17931854 (Pubitemid 350086933)
4. Molecular Detection of Colorectal Neoplasia. DA Ahlquist, Gastroenterology 2010 138 2127 2139 10.1053/j.gastro.2010.01.055 20420950
5. A novel role of serum cytochrome c as a tumor marker in patients with operable cancer. A Osaka, H Hasegawa, Y Yamada, K Yanagihara, T Hayashi, M Mine, M Aoyama, T Sawada, J Cancer Res Clin Oncol 2009 135 371 377 10.1007/s00432-008-0479-y 18825408
6. Circulating nucleosomes in serum. S Holdenrieder, P Stieber, MH Boden, M Busch, JV Pawel, A Schalhom, D Nagel, D Seidel, Ann N Y Acad Sci 2001 945 93 102 11708501 (Pubitemid 33022437)
7. Programmed Cell Death Pathways and Current Antitumor Targets. ML Tan, JP Ooi, N Ismail, AIH Moad, TST Muhammad, Pharmaceutical Research 2009 26 1547 1560 10.1007/s11095-009-9895-1 19407932
8. The biochemistry of apoptosis. MO Hengartner, Nature 2000 407 770 774 10.1038/35037710 11048727
9. Inhibition of single minded 2 gene expression mediates tumor-selective apoptosis and differentiation in human colon cancer cells. MJ Aleman, MP De Young, M Tress, P Ketting, GW Perry, YR Nara, Proc Natl Acad Sci 2005 102 12765 12770 10.1073/pnas.0505484102 16129820 (Pubitemid 41279440)
10. Membrane rafts segregate pro-and anti-apoptotic insulin like growth factor- 1 receptor signaling in colon carcinoma cells stimulated by membranes of tumor necrosis factor superfamily. M Remacle-Bonnet, F Garrouste, G Baillat, F Andre, J Marvaldi, G Pommier, Am J Pathol 2005 167 761 773 10.1016/S0002- 9440(10)62049-4 16127155 (Pubitemid 41216360)
11. Serum biomarkers of cell death for monitoring therapy response of gastrointestinal carcinomas. D Brandt, X Volkmann, M Anstatt, F Langer, MP Manns, K Schulze-Osthoff, H Bantel, European journal of cancer 2010 4 1464 1473
12. Apoptotic markers in cancer. S Holdenrieder, P Stieber, Clinical Biochemistry 2004 37 605 617 10.1016/j.clinbiochem.2004.05.003 15234242 (Pubitemid 38845023)
13. Time between onset of apoptosis and release of nucleosomes from apoptotic cells: putative implications for systemic lupus erythematosus. AEM Van Nieuwenhuijze, T Van Lopik, RJT Smeenk, LA Aarden, Ann Rheum Dis 2003 62 10 14 10.1136/ard.62.1.10 12480662
14. The role of tumor cell adhesion as an important factor in formation of distant colorectal metastasis. J Haier, GL Nicolson, Dis Colon Rectum 2001 44 876 884 10.1007/BF02234713 11391152 (Pubitemid 32522080)
15. Unexplained rising carcinoembryonic antigen (CEA) in the postoperative surveillance of colorectal cancer: the utility of positron emission tomography (PET). P Flamen, OS Hoekstra, F Homans, E Van Cutsem, A Maes, S Stroobants, M Peeters, F Penninckx, L Filez, RP Bleichrodt, L Mortelmans, European Journal of Cancer 2001 37 862 869 10.1016/S0959-8049(01)00049-1 11313174 (Pubitemid 32323964)
16. Clinical utility of biochemical markers of CRC: European Group on Tumor marker (EGTM) guidelines. MJ Duffy, A Van Dalen, C Haglund, L Hansson, R Klapdof, R Lamerz, O Nilsson, C Sturgron, O Toplocan, Eur J Cancer 2003 39 718 727 10.1016/S0959-8049(02)00811-0 12651195 (Pubitemid 36315986)
17. The prognostic significance of direct extension of carcinoma of the colon and rectum. VB Astler, FA Coller, Ann Sur 1954 139 846 852 10.1097/00000658- 195406000-00015
18. PN Campbell, AD Smith, Biochemistry illustrated Edinburgh: Churchill Livingstone 2000
19. Elevated nucleosome levels in systemic inflammation and sepsis. S Zeerleder, B Zwart, WA Wuillemin, LA Aarden, ABJ Groeneveld, C Caliezit, AEM Van Nieuwenhuijze, GJ Van Mierlo, AJM Eerenberg, B Lammle, CE Hack, Crit Care Med 2003 31 1947 1951 10.1097/01.CCM.0000074719.40109.95 12847387 (Pubitemid 36900748)
20. Carcinoembryonic antigen, a human tumor marker, functions as intercellular molecule. S Benchimol, A Fuks, S Jothy, N Beauchemin, K Shirota, CP Stanners, Cell 1989 57 327 334 10.1016/0092-8674(89)90970-7 2702691 (Pubitemid 19112371)
21. Improvement of carcinoembryonic antigen-specific prodrug gene therapy for experimental.cancer colon. K Ueda, M Iwahashi, M Nakamori, Surgery 2003 133 309 317 10.1067/msy.2003.73 12660644 (Pubitemid 36390794)
22. The potential of carcinoembryonic antigen, p53, Ki-67 and glutathione S-transferase- as clinico-histopathological markers for colorectal cancer. Z He, C Shi, H Wen, F Li, B Wang, J Wang, Journal of Biomedical Research 2010 24 51 57 10.1016/S1674-8301(10)60008-5
23. Colorectal cancer screening in the elderly population: disparities by dual Medicare-Medicaid enrollment status. SM Koroukian, F Xu, A Dor, GS Woper, Health Ser Res 2006 41 2136 2154 10.1111/j.1475-6773.2006.00585.x (Pubitemid 44760147)
24. The prognostic value of pre-operative serum levels of CEA, CA 19-9 and CA 72-4 in patients with colorectal cancer. CX Zheng, WH Zhan, JZ Zhao, D Zheng, DP Wang, YL He, ZQ Zheng, World J Gastroenterol 2001 7 431 434 11819806 (Pubitemid 32586534)
25. Clinical Relevance of Circulating Nucleosomes in Cancer. S Holdenrieder, D Nagel, A Schalhorn, V Heinemann, R Wilkowski, J Von Pawel, H Raith, K Feldmann, AE Kremer, S Muller, S Geiger, GF Hamann, D Seidel, P Stieber, Ann N Y Acad Sci 2008 1137 180 189 10.1196/annals.1448.012 18837945
26. Acute-phase protein response, survival and tumor recurrence in patients with colorectal cancer. SJ Wigmore, AJ McMahon, CM Sturgeon, CH Fearon, Br J Surg 2001 88 255 260 10.1046/j.1365-2168.2001.01669.x 11167877 (Pubitemid 32142715)
27. Correlation of apoptosis with tumor cell differentiation, progression and HPV infection in cervical carcinoma. Y Shoji, M Saegusa, Y Tanako, M Ohbu, I Okayasu, J Clin Pathol 1996 49 134 138 10.1136/jcp.49.2.134 8655679 (Pubitemid 26064919)
28. Differentiation: A suitable strategy for cancer chemotherapy. HM Beere, JA Hickman, Anticancer drug Des 1993 8 299 322 8240658 (Pubitemid 23343546)
29. Phytic acid in wheat bran affects colon morphology, cell differentiation and apoptosis. M Jenab, LU Thompson, Carcinogenesis 2000 21 1547 1552 10.1093/carcin/21.8.1547 10910957 (Pubitemid 30603979)
30. Nucleosomes in colorectal cancer patients during radiochemotherapy. K Andreas, H Stefan, S Petra, W Ralf, N Dorothea, S Dietrich, Tumor Biology 2006 27 235 242 10.1159/000094694 16864976 (Pubitemid 44260248)
31. Tumor markers. DW Chan, S Sell, Tietz Textbook of Clinical Chemistry Philadelphia: W B Saunders Company, Burtis CA, Ashwood ER, 1999 722 724
32. Comparison of carcinoembryonic antigen in tissue and serum with grade and stage of colon cancer. J Bhatnagar, H Tewari, M Bhatnagar, GE Austin, Anticancer Res 1999 19 2181 2187 10472328 (Pubitemid 29392519)